Citigroup’s Innoviva INVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-13,900
Closed -$243K 7723
2018
Q4
$243K Sell
13,900
-2,700
-16% -$43.9K ﹤0.01% 4825
2018
Q3
$253K Buy
16,600
+2,000
+14% +$28.8K ﹤0.01% 4999
2018
Q2
$201K Buy
14,600
+700
+5% +$10.5K ﹤0.01% 5064
2018
Q1
$232K Sell
13,900
-7,200
-34% -$111K ﹤0.01% 4820
2017
Q4
$299K Buy
+21,100
New +$281K ﹤0.01% 4647
2017
Q3
Sell
-3,000
Closed -$38K 7331
2017
Q2
$38K Sell
3,000
-2,100
-41% -$26.3K ﹤0.01% 5963
2017
Q1
$71K Buy
5,100
+3,000
+143% +$35.3K ﹤0.01% 5456
2016
Q4
$22K Sell
2,100
-400
-16% -$4.2K ﹤0.01% 6488
2016
Q3
$27K Buy
+2,500
New +$29.2K ﹤0.01% 6052
2016
Q2
Sell
-200
Closed -$3K 7217
2016
Q1
$3K Sell
200
-300
-60% -$3.29K ﹤0.01% 7136
2015
Q4
$5K Sell
500
-300
-38% -$2.76K ﹤0.01% 7038
2015
Q3
$6K Sell
800
-300
-27% -$4.08K ﹤0.01% 6644
2015
Q2
$20K Buy
+1,100
New +$18.9K ﹤0.01% 6103

Other funds holding INVA

Citigroup's INVA Position: Q1 2026 in Review

Citigroup reduced its Innoviva (INVA) stake by 41% in Q1 2026, selling an estimated $469K and leaving 31,732 shares worth $739K. The position accounts for ﹤0.01% of the portfolio, ranked #3309.

Citigroup first reported a position in INVA in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.83M in Q4 2018. 286 funds tracked by Wall St. Rank hold INVA as of Q1 2026.

  • Citigroup held 31,732 shares of Innoviva worth $739K as of Q1 2026.
  • Citigroup sold 21,780 Innoviva shares in Q1 2026, an estimated $469K.
  • Innoviva made up ﹤0.01% of Citigroup's portfolio in Q1 2026, its #3309 holding.
  • Citigroup first reported a position in Innoviva in Q2 2013 and has held it in 52 quarters since.
  • Citigroup's Innoviva position peaked at $2.83M in Q4 2018.
  • 286 funds tracked by Wall St. Rank held Innoviva as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.